{
    "id": "52831900",
    "text": "Ipatasertib (RG7440) is an experimental cancer drug in development by Roche. It is a small molecule inhibitor of AKT, which is a key component of the PI3K/AKT pathway. It was discovered by Array Biopharma and is currently in phase II trials for treatment of breast cancer.https://www.clinicaltrials.gov/ct2/show/NCT02301988 In vitro, ipatasertib showed activity against all three isoforms of Akt.Lin K, Friedman L, Gloor S, Gross S, Liederer BM, Mitchell I, et al. Preclinical characterization of GDC-0068, a novel selective ATP competitive inhibitor of Akt. 22nd-EORTC-NCI-AACR-2010 2010; abstr. 79 == References == Category:Experimental cancer drugs Category:Drugs not assigned an ATC code Category:Protein kinase inhibitors Category:Chloroarenes Category:Piperazines Category:Isopropyl compounds Category:Secondary alcohols ",
    "title": "Ipatasertib"
}